Ionis Pharmaceuticals: Needham cuts target price to $54 from $86
IONS•Needham cut its target price for Ionis Pharmaceuticals to $54 from $86.
Related News
Enerpac Tool Group presents strategy targeting growth 200-300 basis points above market
EPAC•
Autoliv appoints Joachim Rosenberg as independent director
ALV•
SS&C study finds wider pricing gaps in less liquid fixed-income assets
SSNC•
American Healthcare REIT, Inc.: Raymond James raises target price to $72 from $62
AHR•
No impact on production at Tata India iPhone parts factory as worker deaths occurred while plant shut for festive holidays
AAPL•